Additional Proxy Soliciting Materials (definitive) (defa14a)
December 23 2022 - 05:24PM
Edgar (US Regulatory)
As filed with the Securities and
Exchange Commission on December
[XX], 2022
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrant x
Filed by a Party other than the Registrant ¨
Check the appropriate box:
¨ |
Preliminary Proxy Statement |
|
|
¨ |
Confidential, for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2)) |
|
|
¨ |
Definitive Proxy
Statement |
|
|
x |
Definitive Additional Materials |
|
|
¨ |
Soliciting Material Pursuant to §240.14a-12 |
|
|
Northwest Biotherapeutics, Inc.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the
Registrant)
Payment of Filing Fee (Check the appropriate box):
¨ |
Fee paid previously with preliminary materials. |
|
|
¨ |
Fee computed on table in exhibit required by Item 25(b) per
Exchange Act Rules 14a-6(i)(1) and 0-11. |
NORTHWEST BIOTHERAPEUTICS, INC.
STATEMENT REGARDING ACCESS TO AUDIO-ONLY CONNECTION
FOR THE ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON DECEMBER 30, 2022
Northwest Biotherapeutics, Inc. (the “Company”) is filing this
supplemental disclosure to advise stockholders on how they may
connect from a remote location through an audio-only link to the
Annual Meeting of Stockholders to be held on Friday, December 30,
2022 at 1:30 p.m. Eastern Time (the “Annual Meeting”). Stockholders
who cannot attend the Annual Meeting in person will need to vote
prior to the meeting as the audio-only link will not enable voting
during the meeting.
The Annual Meeting may be accessed by stockholders and guests in
audio-only mode by accessing
https://gibsondunn.zoom.us/j/96658488330?pwd=S3lnRHVUQ1ZyUFJMNnVxZCs3QWdwZz09
and entering passcode: 113191.
Alternatively, the Annual Meeting may be accessed telephonically by
dialing (213) 338-8477 or (619) 990-6833 and entering
webinar ID: 966 5848 8330 and passcode: 113191.
Following the Annual Meeting, there will be an informal discussion
period as time permits. Stockholders may submit written questions
to the Company prior to 6:00 p.m. Eastern Time on Tuesday, December
27, 2022.
The Company strongly encourages its eligible stockholders to vote
and submit their proxies in advance of the Annual Meeting by
methods described in the proxy materials distributed to
stockholders on or about December 5, 2022. If stockholders have
already voted, no additional action is required.
Additional details regarding the Annual Meeting and the matters to
be presented to stockholders at the Annual Meeting are available in
the Company’s definitive proxy statement, filed with the Securities
and Exchange Commission on December 5, 2022. Stockholders may also
access the definitive proxy statement and other proxy materials by
visiting: http://www.edocumentview.com/NWBO.
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Mar 2023 to Mar 2023
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Mar 2022 to Mar 2023